Misuse of prophylactic antibiotics and prevalence of postoperative wound infection in obstetrics and gynecology department in a Sudanese hospital

Abstract

Purpose: This study was conducted to audit prophylactic antibiotic use and to quantify the rate of wound infection. Methods: Across-sectional prospective study was conducted in the Obstetrics and Gynecology Department in Khartoum Teaching Hospital, Sudan during March 1st to 31st October 2010. All Patients (aged >18 years) were included. Results: Overall 725 patients were included. The performed surgical procedures were 751; of these 578 (76.9%) were Caesarean sections. Overall rate of wound infection was 7.8%. The rate of wound infection among patients operated on for caesarean section and abdominal hysterectomy was 8.3%, and 9.2%, respectively. Multivariate logistic analysis showed that body mass index [BMI] ≥ 30 kg/m2 OR 2.1, 95% CI (1.1 - 4.0), (P = 0.019) was the major independent risk factor for occurrence of wound infection. Evaluation of prescriptions’ parameters against the stated criteria showed that 113 (15.8%) patients were given antibiotics with adequate spectrum of activity, 611 (85.3%) given sub-dose/s, 83 (11.6%) received the first preoperative dose/s in a proper time window, and 716 (100%) had prophylaxis for extended duration. Overall conformity to the stated criteria for the evaluation of prescription’s parameters was not achieved in all prescriptions. Conclusions: In this setting, antibiotics were irrationally used and wound infection rate was high, and the situation calls for multiple interventions to correct the situation, through the activation of the infection control committee in the hospital and development of antimicrobial subcommittee to develop policies for the use and auditing of prophylactic antibiotics.

Share and Cite:

Elbur, A. , Yousif, M. , El Sayed, A. and Abdel-Rahman, M. (2014) Misuse of prophylactic antibiotics and prevalence of postoperative wound infection in obstetrics and gynecology department in a Sudanese hospital. Health, 6, 158-164. doi: 10.4236/health.2014.62025.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Kirkland, K.B., Briggs, J.P., Trivette, S.L., Wilkinson, W.E. and Sexton, D.J. (1999) The impact of surgical-site infections in the1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infection Control and Hospital Epidemiology, 20, 725-730.
http://dx.doi.org/10.1086/501572
[2] Merle, V., Germain, J.M., Chamouni, P., Daubert, H., Froment, L., Michot, F., et al. (2000) Assessments of prolonged hospital stay attributable to surgical site infections using appropriateness evaluation protocol. American Journal of Infection Control, 28, 109-115.
http://dx.doi.org/10.1067/mic.2000.102353
[3] Guaschino, S., De Santo, D. and De Seta, F. (2002) New perspectives in antibiotic prophylaxis for obstetric and gynecological surgery. Journal of Hospital Infection, 50, S513-S516. http://dx.doi.org/10.1053/jhin.2001.1123
[4] Gibbs, R.S. (1980) Clinical risk factors for puerperal infection. Obstetrics & Gynecology, 55, 178S-184S.
http://dx.doi.org/10.1097/00006250-198003001-00045
[5] Henderson, E. and Love, E.J. (1995) Incidence of hospital-acquired infections associated with caesarean section. Journal of Hospital Infection, 29, 245-255.
http://dx.doi.org/10.1016/0195-6701(95)90271-6
[6] Mangram, A.J., Horan, T.C., Pearson, M.L., Silver, L.C. and Jarvis, W.R. (1999) Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. American Journal of Infection Control, 27, 97-132.
http://dx.doi.org/10.1016/S0196-6553(99)70088-X
[7] Classen, D.C., Evans, R.S., Pestotnik, S.L., Horn, S.D., Menlove, R.L. and Burke, J.P. (1992) The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. The New England Journal of Medicine, 32, 281-286.
http://dx.doi.org/10.1056/NEJM199201303260501
[8] McDonald, M., Grabsch, E., Marshall, C. and Forbes, A. (1998) Single-versus multiple-dose antimicrobial prophylaxis for major surgery: A systematic review. Australian and New Zealand Journal of Surgery, 68, 388-396.
http://dx.doi.org/10.1111/j.1445-2197.1998.tb04785.x
[9] Harbarth, S., Samore, H.M., Lichtenberg, D. and Carmeli, Y. (2000) Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation, 101, 2916-2921.
http://dx.doi.org/10.1161/01.CIR.101.25.2916
[10] Smaill, F. and Hofmeyr, G.J. (2010) Antibiotic prophylaxis for cesarean section. Cochrane Database of Systematic Reviews, 1, Article ID: CD000933.
http://dx.doi.org/10.1002/14651858.CD000933.pub2
[11] Kwarteng, F., Ahluwalia, B. and Osborne, N.G. (2008) Antibiotics prophylaxis in gynecology. Journal of Gynecologic Surgery, 24, 175-179.
[12] Horan, T.C., Gaynes, R.P., Martone, W.J., Jarvis, W.R. and Emori, T.G. (1992) CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infection Control and Hospital Epidemiology, 13, 606-609.
http://dx.doi.org/10.1086/646436
[13] Scottish Intercollegiate Guidelines Network (2008) Antibiotic prophylaxis in surgery. A national clinical guideline.
http://www.sign.ac.uk/pdf/sign104.pdf
[14] American Society of Health—System Pharmacists (ASHP) (2012) ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery.
http://www.ashp.org/s_ashp/docs/files/BP07/TG_Surgical.pdf
[15] Eriksen, H.M., Saether, A.R., Lower, H.L., Vangen, S., Hjetland, R., Lundmark, H., et al. (2009) Infection after cesarean sections. Tidsskrift for Den Norske Legeforening, 129, 618-622.
http://dx.doi.org/10.4045/tidsskr.09.24093
[16] Kaplan, N.M., Smadi, A.A., Al-Tanni, M.I. and El-Qudah, M.A. (2003) Microbiology of wound infection after cesarean in a Jordanian hospital. Eastern Mediterranean Health Journal, 9, 1068-1074.
[17] National Nosocomial Infections Surveillance System (2004) National nosocomial Infections surveillance (NNIS) system report, data summary from January 1992 through June 2004. American Journal of Infection Control, 32, 470-485. http://dx.doi.org/10.1016/j.ajic.2004.10.001
[18] Schneid-Kofman, N., Sheiner, E., Levy, A. and Holcberg, G. (2005) Risk factors for wound infection following cesarean deliveries. International Journal of Gynecology & Obstetrics, 90, 10-15.
http://dx.doi.org/10.1016/j.ijgo.2005.03.020
[19] Wloch, C., Wilson, J., Lamagni, T., Harrington, P., Charlett, A. and Sheridan, E. (2012) Risk factors for surgical site infection following caesarean section in England: Results from a multicentre cohort study. BJOG, 119, 1324-1333.
http://dx.doi.org/10.1111/j.1471-0528.2012.03452.x
[20] Huskins, W.C., Ba-Thike, K., Festin, M.R., Limpongsanurak, S., Lumbiganon, P., Peedicayil, A., et al. (2001) An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. International Journal of Gynecology & Obstetrics, 73, 141-145.
http://dx.doi.org/10.1016/S0020-7292(01)00365-4
[21] Taylor, G., Herrick, T. and Mah, M. (1998) Wound infections after hysterectomy: Opportunities for practice improvement. American Journal of Infection Control, 26, 254-257.
http://dx.doi.org/10.1016/S0196-6553(98)80009-6
[22] Kalman, D. and Barriere, S.L. (1990) Review of the pharmacology, pharmacokinetics and clinical use of cephalosporin. Texas Heart Institute Journal, 17, 203-215.
[23] Treatment guidelines from the medical letter. (2009) Antimicrobial Prophylaxis for Surgery, 7, 47-51.
[24] Choi, W.S., Song, J.Y., Hwang, J.H., Kim, N.S., Cheong, H.J., et al. (2007) Appropriateness of anti-biotic prophylaxis for major surgery in Korea. Infection Control and Hospital Epidemiology, 28, 997-1002.
http://dx.doi.org/10.1086/519180
[25] Van Eyk, N. and Van Schalkwyk, J. for Infectious Diseases Committee (2012) Antibiotic prophylaxis ingynaecologic procedures. Journal of Obstetrics and Gynaecology Canada, 34, 382-391.
[26] Giuliani, B., Periti, E. and Mecacci, F. (1999) Antimicrobial prophylaxis in obstetric and gyne-cological surgery. Journal of Chemotherapy, 11, 577-580.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.